Product Description

CONQUET 200 contains Quetiapine Fumarate, an atypical antipsychotic designed for the effective management of schizophrenia and bipolar disorder. It works by antagonizing dopamine and serotonin receptors in the brain, helping restore neurotransmitter balance to improve mood, thinking, and behavior. CONQUET 200 helps reduce psychotic symptoms, stabilize mood fluctuations, and support emotional well-being.

The formulation is effective in managing manic and depressive episodes of bipolar disorder and serves as an adjunctive therapy in major depressive disorder. Its calming and sedative properties also assist in controlling anxiety symptoms and sleep disturbances associated with psychiatric conditions, thereby improving overall patient functioning and quality of life.

Indications:

• • Treatment of schizophrenia
  • Management of bipolar disorder (mania and depressive episodes)
  • Adjunct therapy in major depressive disorder (MDD)
  • Management of anxiety symptoms associated with mood disorders
  • Management of sleep disturbances (insomnia) associated with psychiatric conditions

Therapeutic Segment Positioning:

Antipsychotic